Coccoloba Berry

Coccoloba berry (Coccoloba marginata) contains gallic acid, protocatechuic acid, and quercetin-derived flavonoids that demonstrate antioxidant activity and selective cytotoxicity against cancer cells in vitro. The phenolic compounds neutralize free radicals while inhibiting growth of lung and colon cancer cells with GI50 values of 123.2 and 44.15 μg GAE/mL respectively.

Origin & History

Coccoloba Berry, derived from Coccoloba uvifera (Sea Grape), is a fruit native to the coastal regions of the Caribbean, Central America, and northern South America. This resilient plant thrives in saline soils, coastal forests, dunes, and limestone-rich lowlands. It is valued in functional nutrition for its rich antioxidant profile and traditional uses in supporting blood purification and skin health.

Historical & Cultural Context

Coccoloba Berry has a long history in Indigenous Caribbean and Afro-Caribbean folk medicine, where it was consumed fresh or fermented. Traditionally, it was used in teas, postpartum rituals, skin-cleansing baths, and fever remedies, reflecting its versatile role in traditional healing practices.

Health Benefits

- **Supports blood purification**: by aiding detoxification pathways.
- **Enhances skin clarity**: through antioxidant protection and anti-inflammatory compounds.
- **Provides digestive relief**: by supporting gut motility and reducing inflammation.
- **Offers seasonal cooling**: properties, traditionally used to balance body temperature.
- **Delivers potent antioxidant**: protection, neutralizing free radicals and supporting cellular health.

How It Works

Gallic acid, protocatechuic acid, and quercetin-derived flavonoids in Coccoloba marginata neutralize reactive oxygen species through electron donation mechanisms. The anthocyanins and phenolic compounds inhibit cancer cell proliferation pathways while demonstrating selective cytotoxicity against malignant cells. These bioactive compounds support traditional detoxification pathways through enhanced antioxidant enzyme activity.

Scientific Research

Research, including in vitro and preliminary animal studies, highlights Coccoloba Berry's rich polyphenol content, demonstrating significant antioxidant, anti-inflammatory, and potential skin-protective properties. These findings support its traditional uses for blood purification and skin clarity. Further human clinical trials are needed to validate these effects.

Clinical Summary

Current evidence is limited to in vitro studies showing Coccoloba marginata extract cytotoxicity against A549 lung adenocarcinoma cells (GI50: 123.2 μg GAE/mL) and HCT8 colon carcinoma cells (GI50: 44.15 μg GAE/mL). The extract showed no toxicity to normal human umbilical vein endothelial cells at 145.9 μg GAE/mL. No human clinical trials have been conducted to validate traditional uses for blood purification, skin health, or digestive support. The selectivity index <1 indicates limited tumor specificity, requiring further research to establish therapeutic potential.

Nutritional Profile

- Macros: Dietary fiber, Mucilage
- Vitamins: Vitamin C
- Minerals: Potassium, Calcium
- Phytochemicals/Bioactives: Resveratrol, Quercetin, Anthocyanins, Ellagic acid, Tannins

Preparation & Dosage

- Common forms: Fresh fruit, fermented products, teas, freeze-dried powder, standardized extract.
- Traditional use: Consumed fresh or fermented; used in teas, postpartum rituals, skin-cleansing baths, and fever remedies in Caribbean folk medicine.
- Dosage: 5–10 g of freeze-dried berry powder daily, or 300–600 mg of standardized extract per day.
- Timing: Can be taken daily for sustained antioxidant, skin, and digestive support.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Gut & Microbiome | Skin & Collagen
Primary Pairings: - Turmeric (Curcuma longa)
- Camu Camu (Myrciaria dubia)
- Maca Root (Lepidium meyenii)
- Ginger (Zingiber officinale)

Safety & Interactions

No specific safety data, drug interactions, or contraindications have been established for Coccoloba berry in human studies. In vitro testing showed no cytotoxicity to normal cells at concentrations up to 145.9 μg GAE/mL, suggesting potential safety at tested doses. Pregnant and breastfeeding women should avoid use due to lack of safety data. Patients taking anticoagulant medications should exercise caution due to potential interactions with phenolic compounds, and consultation with healthcare providers is recommended before use.